| scholarly article | Q13442814 |
| P2093 | author name string | Mel S Lee | |
| Chih-Hsiang Chang | |||
| Dave W Chen | |||
| Steve W N Ueng | |||
| Yuhan Chang | |||
| P2860 | cites work | Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee arthroplasty | Q30441144 |
| Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis | Q33413136 | ||
| Clinical pharmacology of aminocaproic and tranexamic acids | Q34302597 | ||
| Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty | Q34477030 | ||
| Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery | Q35548763 | ||
| Anemia and postoperative rehabilitation | Q35589373 | ||
| Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. | Q35639452 | ||
| Anemia and clinical outcomes | Q36143297 | ||
| Lateral position reduces blood loss in hip replacement surgery: a prospective randomized study of 74 patients | Q36751255 | ||
| Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials | Q36969965 | ||
| Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial | Q37253019 | ||
| Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty | Q37253804 | ||
| Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention | Q37384093 | ||
| Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. | Q37825357 | ||
| Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. | Q40408432 | ||
| A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery | Q40732008 | ||
| One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty | Q40924017 | ||
| Blood transfusion in orthopaedic operations | Q41074057 | ||
| Prediction of blood volume in normal human adults. | Q41564951 | ||
| Diffusion of tranexamic acid to the joint | Q41850938 | ||
| Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial | Q42170476 | ||
| Effects of tranexamic acid on blood loss during total hip arthroplasty | Q42771522 | ||
| Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. | Q42837549 | ||
| The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia | Q43200651 | ||
| Reduction of blood loss with tranexamic acid in primary total hip replacement surgery | Q43723797 | ||
| Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study | Q43796208 | ||
| Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study | Q44230808 | ||
| Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement | Q44404988 | ||
| The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement | Q44702973 | ||
| Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery | Q44938806 | ||
| Preoperative use of epoietin beta in total hip replacement: a prospective study. | Q45012670 | ||
| Effect of anaemia and cardiovascular disease on surgical mortality and morbidity | Q45093142 | ||
| Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). | Q46468416 | ||
| Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. | Q46697864 | ||
| Two-dose epoetin alfa reduces blood transfusions compared with autologous donation. | Q47252086 | ||
| An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. | Q50536524 | ||
| Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. | Q51407863 | ||
| Hemodilution with other blood reinfusion techniques in total hip arthroplasty. | Q51542008 | ||
| Efficacy of intraoperative blood collection and reinfusion in revision total hip arthroplasty. | Q51794971 | ||
| Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial. | Q51872004 | ||
| Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. | Q64971721 | ||
| Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. COPES Study Group | Q72226616 | ||
| Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs | Q73592253 | ||
| A prospective, randomized study of preoperative autologous donation for hip replacement surgery | Q74606550 | ||
| Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty | Q77894738 | ||
| An analysis of blood management in patients having a total hip or knee arthroplasty | Q78108769 | ||
| Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines | Q79610527 | ||
| The effect of patient position on blood loss in primary cemented total hip arthroplasty | Q80537745 | ||
| Post-operative blood salvage with autologous retransfusion in primary total hip replacement | Q81039475 | ||
| Erythropoietin as adjuvant to pre-operative autologous blood donation in total hip arthroplasty: new algorithm for use | Q81083753 | ||
| The utility of the perioperative autologous transfusion system OrthoPAT in total hip replacement surgery: a prospective study | Q81166871 | ||
| Autologous blood transfusion in total hip arthroplasty | Q81204356 | ||
| Perioperative autotransfusion in total hip and knee arthroplasty | Q82420215 | ||
| Tranexamic acid for reduction of blood loss during total hip arthroplasty | Q84390004 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tranexamic acid | Q418666 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1552-1557 | |
| P577 | publication date | 2014-01-03 | |
| P1433 | published in | Clinical Orthopaedics and Related Research | Q5133783 |
| P1476 | title | Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty | |
| P478 | volume | 472 |
| Q42706668 | A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA |
| Q50981576 | Additional intraarticular tranexamic acid further reduced postoperative blood loss compared to intravenous and topical bathed tranexamic acid in total hip arthroplasty: a retrospective sequential series study. |
| Q92979055 | Clinical application of auricular point sticking in perioperative hemostasis for elderly patients with intertrochanteric fractures of the femur |
| Q41341203 | Effect of Tranexamic Acid on Hematologic Values and Blood Loss in Reverse Total Shoulder Arthroplasty |
| Q49556752 | Efficacy and safety of tranexamic acid in total hip replacement: A PRISMA-compliant meta-analysis of 25 randomized controlled trials. |
| Q58701289 | Efficacy of topical tranexamic acid within a blood-saving programme for primary total hip arthroplasty: a pragmatic, open-label randomised study |
| Q53150324 | Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder. |
| Q35201182 | Hidden blood loss and its influential factors after total hip arthroplasty |
| Q58591719 | Intra-Articular Tranexamic Acid Injection During the Hip Hemi-Arthroplasty in Elderly Patients: A Retrospective Study |
| Q53667154 | Is a preoperative group and save necessary for enhanced recovery joint replacement patients? |
| Q36552848 | Longtime soaking of high concentration tranexamic acid in total hip arthroplasty: A prospective randomized controlled trial in 224 patients |
| Q26740504 | Patient Blood Management in Hip Replacement Arthroplasty |
| Q36515685 | Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. |
| Q26751278 | Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review |
| Q28073337 | The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis |
| Q35050330 | Topical tranexamic Acid does not affect electrophysiologic or neurovascular sciatic nerve markers in an animal model |
| Q64239742 | Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial |
| Q26783461 | Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence |
| Q90662028 | Use of Topical Tranexamic Acid to Reduce Blood Loss in Single-Level Transforaminal Lumbar Interbody Fusion |
Search more.